CollPlant Biotechnologies Ltd.
CLGN
$2.35
-$0.07-2.89%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | 17.30% | -173.06% | -6.54% | 0.05% | |
| Total Depreciation and Amortization | -14.79% | -1.88% | -3.40% | -3.20% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -3.01% | 19.77% | 4.89% | -2.76% | |
| Change in Net Operating Assets | -110.74% | 94.25% | 310.41% | 3,826.05% | |
| Cash from Operations | -47.72% | -4.91% | 29.92% | 312.75% | |
| Capital Expenditure | 74.24% | 40.06% | 20.21% | 21.36% | |
| Sale of Property, Plant, and Equipment | -98.53% | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 100.00% | 3.39% | -1,141.18% | 100.00% | |
| Cash from Investing | 84.41% | 34.60% | -22.37% | 24.53% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -100.00% | -100.00% | -- | |
| Foreign Exchange rate Adjustments | -69.85% | 27.16% | 118.68% | -578.57% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -37.49% | -2.18% | 20.29% | 290.14% | |